Epidemiology, Pathophysiology, Diagnosis and Management of Atrial Functional Mitral Regurgitation: An Expert Opinion Paper
ESC Heart Failure · 2025
DOI: 10.1002/ehf2.15405 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Matteo Pagnesi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of…. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Disease Management, Heart Atria, Mitral Valve. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Atrial functional mitral regurgitation (AFMR) is an increasingly recognized subtype of mitral regurgitation, characterized by left atrial remodelling and mitral annular dilation in the absence of primary mitral valve disease or left ventricular dysfunction. Closely linked to chronic atrial fibrillation and heart failure with preserved ejection fraction, AFMR is associated with poor clinical outcomes and represents a growing therapeutic challenge. This expert opinion paper summarizes current evidence on the epidemiology, pathophysiology, diagnosis and management strategies, including medical therapy and emerging data supporting surgical and transcatheter interventions in selected patients. However, data from prospective controlled clinical trials are still lacking. Future research is needed to refine patient selection, long-term outcomes and to support evidence-based recommendations for this increasingly prevalent condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
- Institue of Cardiology, ASST Cremona, Cremona, Italy.
- Department of Cardiac Surgery, San Raffaele Scientific Institute, Milan, Italy.
- Heart and Vascular Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- American Medical Center, American Heart Institute, Nicosia, Cyprus.
- Department of Cardiovascular Medicine, Faculty of Medicine, Kasr Al Ainy, Cairo University, Giza, Egypt.
ORCID-Profile: Matteo Pagnesi
Zitieren
APA
Pagnesi, M., Riccardi, M., Maisano, F., Grapsa, J., Barberis, V., Abdelhamid, M., Antohi, E. L., Arfsten, H., Karam, N., Muraru, D., Rommel, K. P., Sannino, A., Mullens, W., Adamo, M., & Metra, M. (2025). Epidemiology, Pathophysiology, Diagnosis and Management of Atrial Functional Mitral Regurgitation: An Expert Opinion Paper. ESC Heart Failure. https://doi.org/10.1002/ehf2.15405
Vancouver
Pagnesi M, Riccardi M, Maisano F, Grapsa J, Barberis V, Abdelhamid M, et al. Epidemiology, Pathophysiology, Diagnosis and Management of Atrial Functional Mitral Regurgitation: An Expert Opinion Paper. ESC Heart Failure. 2025. doi:10.1002/ehf2.15405
BibTeX
@article{Pagnesi2025,
author = {Pagnesi, Matteo and Riccardi, Mauro and Maisano, Francesco and Grapsa, Julia and Barberis, Vassilis and Abdelhamid, Magdy and Antohi, Elena-Laura and Arfsten, Henrike and Karam, Nicole and Muraru, Denisa and Rommel, Karl-Philipp and Sannino, Anna and Mullens, Wilfried and Adamo, Marianna and Metra, Marco},
title = {Epidemiology, Pathophysiology, Diagnosis and Management of Atrial Functional Mitral Regurgitation: An Expert Opinion Paper},
journal = {ESC Heart Failure},
year = {2025},
doi = {10.1002/ehf2.15405}
}
EUVIMED